Combining our immunology and neuroscience expertise, we are continually developing our service offering and expanding to meet client demand.

Our services

Our services

We are developing a range of neurotoxicity services, including developmental neurotoxicity assays (DNT), using our pluripotent stem cell and primary CNS cell-based assay platforms that can support Pharma and non-Pharma clients in their regulatory and safety requirements.

We have a suite of cell-based approaches that include cytotoxicity, viability and proliferation assays, mitochondrial toxicity and calcium influx assays.

Want to find out more?

Our multi-disciplinary teams mitigate risk by employing knowledge, foresight and thought leadership to all our client’s diverse programs enabling the highest chance of success. Get in touch to find out how we can support you.